Effectiveness of Trimethoprim‐Sulfamethoxazole and Metronidazole in the Treatment of Small Intestinal Bacterial Overgrowth in Children Living in a Slum

ABSTRACT Trimethoprim‐sulfamethoxazole and metronidazole were used for 14 days to treat 20 children with small intestine bacterial overgrowth (SIBO). SIBO was diagnosed using the lactulose hydrogen breath test. The breath test was repeated 1 month after treatment, and 19 (95.0%) of 20 children showe...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pediatric gastroenterology and nutrition Vol. 57; no. 3; pp. 316 - 318
Main Authors: Tahan, Soraia, Melli, Lígia Cristina F.L., Mello, Carolina Santos, Rodrigues, Mírian Silva C., Filho, Humberto Bezerra, Morais, Mauro B.
Format: Journal Article
Language:English
Published: Hagerstown, MD by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology 01-09-2013
Lippincott Williams & Wilkins
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Trimethoprim‐sulfamethoxazole and metronidazole were used for 14 days to treat 20 children with small intestine bacterial overgrowth (SIBO). SIBO was diagnosed using the lactulose hydrogen breath test. The breath test was repeated 1 month after treatment, and 19 (95.0%) of 20 children showed no evidence of SIBO (P < 0.001). The area under the individual curves showed that children with SIBO exhibited greater hydrogen production before treatment in both the first hour and between 60 and 180 minutes after the breath test. The treatment did not decrease methane production. In conclusion, trimethoprim‐sulfamethoxazole and metronidazole was effective in treating children with SIBO.
Bibliography:The pharmaceutical support for this work was provided by Daiichi Sankyo Brasil Farmacêutica LTDA, São Paulo, SP, Brazil.
The authors report no conflicts of interest.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0277-2116
1536-4801
DOI:10.1097/MPG.0b013e3182952e93